International team finds a bioactive protein from ancient medicinal plant may help combat melanoma and other cancers
An international team led by scientists from the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine, has found that a protein from the seeds of a plant used for centuries in traditional medicines may be able to halt the spread of melanoma, a lethal form of skin cancer. The study included collaborators from Nagoya University, the University of Michigan and GlaxoSmithKline. The University of Medicine and Dentistry of New Jersey is an academic affiliate of the Cancer Institute of New Jersey.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.